MARC Record from marc_columbia

LEADER: 14466pam a22004334a 4500
001 4754426
005 20221103032512.0
008 031020t20042004paua b 001 0 eng
010 $a 2003066794
015 $aGBA4-Z7596
016 7 $a101194846$2DNLM
020 $a0721603238
035 $a(OCoLC)ocm53286508
035 $a(NNC)4754426
035 $a4754426
040 $aDNLM/DLC$cDLC$dNLM$dUKM$dOrLoB-B
042 $apcc
050 00 $aRC685.A65$bC286 2004
060 00 $a2004 F-857
060 10 $aWG 330$bC26925 2004
082 00 $a616.1/28$222
245 00 $aCardiac electrophysiology :$bfrom cell to bedside /$c[edited by] Douglas P. Zipes, José Jalife.
250 $a4th ed.
260 $aPhiladelphia :$bSaunders,$c[2004], ©2004.
300 $axvi, 1144 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tSodium channels /$rRonald A. Li, Gordon F. Tomaselli and Eduardo Marban -- $gCh. 2.$tCardiac calcium channels /$rDonald M. Bers -- $gCh. 3.$tVoltage-regulated potassium channels /$rGavin Y. Oudit, Rafael J. Ramirez and Peter H. Backx -- $gCh. 4.$tIntracellular signaling and regulation of cardiac ion channels /$rAnant Khositseth, David E. Clapham and Michael J. Ackerman -- $gCh. 5.$tMembrane pumps and exchangers /$rLarry V. Hryshko -- $gCh. 6.$tSarcoplasmic reticulum ion channels /$rGerhard Meissner -- $gCh. 7.$tHCN channels : from genes to function /$rAndreas Ludwig, Juliane Stieber, Sven Moosmang, Stefan Herrmann, Martin Biel and Franz Hofmann -- $gCh. 8.$tMolecular organization and regulation of the cardiac gap junction channel Connexin43 /$rMario Delmar, Heather S. Duffy, Paul L. Sorgen, Steven M. Taffet and David C. Spray -- $gCh. 9.$tBiophysics of normal and abnormal cardiac sodium channel function /$rJeffrey R. Balser -- $gCh. 10.$tGating of cardiac delayed rectifier K[superscript +] channels /$rMichael C. Sanguinetti and Martin Tristani-Firouzi -- $gCh. 11.$tHeart mechanoelectric transduction /$rFrederick Sachs -- $gCh. 12.$tPacemaker channels and normal automaticity /$rDario DiFrancesco -- $gCh. 13.$tBiophysical properties of inward rectifier potassium channels /$rJustus M. B. Anumonwo -- $gCh. 14.$tHomomeric and heteromeric gap junctions /$rAlonso P. Moreno, Volodya Hayrapetyan, Guoqiang Zhong, Agustin D. Martinez and Eric C. Beyer -- $gCh. 15.$tPharmacology of the cardiac sodium channel /$rJonathan C. Makielski, Bin Ye, Timothy J. Kamp and Craig T. January -- $gCh. 16.$tPharmacology of the L-type and T-type channels in the heart /$rXiongwen Chen and Steven R. Houser -- $gCh. 17.$tKCNQ1/KCNE1 macromolecular signaling complex : channel microdomains and human disease /$rSheila J. Carroll, Junko Kurokawa and Robert S. Kass -- $gCh. 18.$tDrug-induced channelopathies /$rCharles Antzelevitch -- $gCh. 19.$tProspects for pharmacologic targeting of gap junction channels /$rMiduturu Srinivas, Heather Duffy, Mario Delmar and David C. Spray -- $gCh. 20.$tHeterogeneous expression of potassium channels in the mammalian myocardium /$rJeanne M. Nerbonne -- $gCh. 21.$tGap junction distribution and regulation in the heart /$rJeffrey E. Saffitz, Deborah L. Lerner and Kathryn A. Yamada -- $gCh. 22.$tCellular mechanisms of sinoatrial activity /$rItsuo Kodama, Haruo Honjo, Halina Dobrzynski and Mark R. Boyett -- $gCh. 23.$tMechanisms of AV nodal excitability and propagation /$rIgor R. Efimov and Vladimir P. Nikolski -- $gCh. 24.$tIntercellular communication and impulse propagation /$rAndre G. Kleber -- $gCh. 25.$tCardiac tissue architecture determines velocity and safety of propagation /$rStephan Rohr and Jan P. Kucera -- $gCh. 26.$tRestitution, repolarization, and alternans as arrhythmogenic substrates /$rKenneth R. Laurita and David S. Rosenbaum -- $gCh. 27.$tMechanoelectric transduction/feedback : prevalence and pathophysiology /$rMax J. Lab -- $gCh. 28.$tIonic mechanisms of cardiac electrical activity : a theoretical approach /$rYoram Rudy -- $gCh. 29.$tTwo-dimensional propagation in cardiac muscle /$rBradley J. Roth -- $gCh. 30.$tThree-dimensional propagation in mathematical models : integrative model of the mouse heart /$rCraig S. Henriquez, Joseph V. Tranquillo, David Weinstein, Edward W. Hsu, Christopher R. Johnson, Felipe Aguel, Claire Larson and Carlos Haro -- $gCh. 31.$tModeling cardiac defibrillation /$rNatalia A. Trayanova, Felipe Aguel, Claire Larson and Carlos Haro -- $gCh. 32.$tMolecular and cellular bases of [beta]-adrenergic and [alpha]-adrenergic modulation of cardiac rhythm /$rSusan E. Steinberg, Richard B. Robinson and Michael R. Rosen -- $gCh. 33.$tNerve sprouting and cardiac arrhythmias /$rLan S. Chen and Peng-Sheng Chen -- $gCh. 34.$tCholinergic atrial fibrillation /$rLeonid V. Rosenshtraukh, Vadim V. Fedorov and Oleg F. Sharifov -- $gCh. 35.$tTheory of reentry /$rMarcel Wellner and Omer Berenfeld -- $gCh. 36.$tNonlinear dynamics of excitation and propagation in cardiac muscle /$rZhilin Qu and Alan Garfinkel -- $gCh. 37.$tRotors and spiral waves in two dimensions /$rLeslie Tung, Nenad Bursac and Felipe Aguel -- $gCh. 38.$tScroll waves in three dimensions /$rArkady M. Pertsov -- $gCh. 39.$tElectrophysiology of the pulmonary veins : mechanisms of initiation of atrial fibrillation /$rJeffrey E. Olgin -- $gCh. 40.$tMechanisms of maintenance of atrial fibrillation /$rOmer Berenfeld -- $gCh. 41.$tElectrical remodeling and chronic atrial fibrillation /$rDavid R. Van Wagoner -- $gCh. 42.$tMechanisms of initiation of ventricular tachyarrhythmias /$rJiashin Wu, Jianyi Wu and Douglas P. Zipes -- $gCh. 43.$tDynamics and molecular mechanisms of ventricular fibrillation in normal hearts /$rJose Jalife -- $gCh. 44.$tMechanisms of ischemic ventricular fibrillation : who's the killer? /$rAlexey V. Zaitsev -- $gCh. 45.$tCellular mechanisms of defibrillation /$rVladimir G. Fast -- $gCh. 46.$tGlobal mechanisms of defibrillation /$rRichard A. Gray -- $gCh. 47.$tDefibrillation waveforms /$rRaymond E. Ideker, Jian Huang and Gregory P. Walcott -- $gCh. 48.$tMouse models of cardiac arrhythmias /$rBarry London -- $gCh. 49.$tHuman molecular genetics and the heart /$rJeffrey A. Towbin and Neil E. Bowles -- $gCh. 50.$tGenetics of long QT, Brugada, and other channelopathies /$rSilvia G. Priori, Ilaria Rivolta and Carlo Napolitano -- $gCh. 51.$tPharmacogenomics of cardiac arrhythmias and impact on drug therapy /$rDan M. Roden -- $gCh. 52.$tSinus rhythm abnormalities /$rDavid Lin and David J. Callans -- $gCh. 53.$tAtrioventricular block and atrioventricular dissociation /$rDavid Schwartzman -- $gCh. 54.$tAtrial flutter : mechanisms, clinical features, and management /$rAlbert L. Waldo -- $gCh. 55.$tAtrial tachycardia /$rKenneth A. Ellenbogen and Mark A. Wood -- $gCh. 56.$tAtrial fibrillation /$rStanley Nattel and Joachim R. Ehrlich -- $gCh. 57.$tJunctional rhythms and junctional tachycardia /$rHakan Oral and S. Adam Strickberger -- $gCh. 58.$tAtrioventricular reentry and variants /$rBradley P. Knight and Fred Morady -- $gCh. 59.$tElectrophysiologic characteristics of atrioventricular nodal reentrant tachycardia : implications for the reentrant circuits /$rDeborah Lockwood, Kenichiro Otomo, Zulu Wang, Sara Foresti, Hiroshi Nakagawa, Karen Beckman, Benjamin J. Scherlag, Eugene Patterson, Ralph Lazzara and Warren M. Jackman -- $gCh. 60.$tAtrial arrhythmias in congenital heart disease /$rJohn K. Triedman -- $gCh. 61.$tVentricular tachycardia in patients with coronary artery disease /$rDavid J. Callans and Mark E. Josephson -- $gCh. 62.$tVentricular tachycardia in patients with dilated cardiomyopathy /$rJoseph M. Galvin and Jeremy N. Ruskin -- $gCh. 63.$tVentricular tachycardia in arrhythmogenic right ventricular cardiomyopathies /$rGuy Fontaine, Paul Fornes, Jean-Louis Hebert, Catherine Prost-Squarcioni, Xavier Jouven, Jean-Sebastien Hulot, Robert Frank and Daniel Thomas -- $gCh. 64.$tVentricular arrhythmias in hypertrophic cardiomyopathy /$rBarry J. Maron -- $gCh. 65.$tVentricular tachycardia in patients with hypertrophy and heart failure /$rMarc A. Vos and Harry J. Crijns -- $gCh. 66.$tVentricular tachycardia in patients following surgery for congenital heart disease /$rGeorge F. Van Hare -- $gCh. 67.$tThe Brugada syndrome /$rPedro Brugada, Ramon Brugada, Charles Antzelevitch, Jeffrey A. Towbin and Josep Brugada -- $gCh. 68.$tCatecholaminergic polymorphic ventricular tachycardia and short-coupled torsades de pointes /$rCarlo Napolitano and Silvia G. Priori -- $gCh. 69.$tArrythmias in patients with neurologic disorders /$rWilliam J. Groh -- $gCh. 70.$tLong QT syndrome - genotype-phenotype considerations /$rPeter J. Schwartz and Silvia G. Priori -- $gCh. 71.$tLong QT syndrome : therapeutic considerations /$rArthur J. Moss and Wojciech Zareba -- $gCh. 72.$tVentricular tachycardia in patients with structurally normal hearts /$rBruce B. Lerman, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal and Sei Iwai -- $gCh. 73.$tBundle branch reentry /$rEmile G. Daoud -- $gCh. 74.$tTorsade de pointes /$rNabil El-Sherif and Gioia Turitto --
505 80 $gCh. 75.$tAccelerated idioventricular rhythm and bidirectional ventricular tachycardia /$rWolfram Grimm and Francis E. Marchlinski -- $gCh. 76.$tVentricular fibrillation /$rAndrew E. Epstein -- $gCh. 77.$tProlonged repolarization and sudden infant death syndrome /$rPeter J. Schwartz and Marco Stramba-Badiale -- $gCh. 78.$tSudden cardiac death /$rRobert J. Myerburg, Alberto Interian, Jr., Jeffrey Simmons and Agustin Castellanos -- $gCh. 79.$tElectrocardiographic manifestations of supernormal conduction, concealed conduction, and exit block /$rMichael J. Kilborn and Mark A. McGuire -- $gCh. 80.$tParasystole /$rAgustin Castellanos, Nadir Saoudi, Federico Moleiro and Robert J. Myerburg -- $gCh. 81.$tDifferential diagnosis of wide QRS complex tachycardia /$rJohn M. Miller, Mithilesh K. Das, Rishi Arora, Cesar Alberte-Lista and Jianyi Wu -- $gCh. 82.$tAssessment of the patient with a cardiac arrhythmia /$rDouglas P. Zipes and William M. Miles -- $gCh. 83.$tExercise-induced cardiac arrhythmias /$rRuey J. Sung, Chi Tai Kuo and Wen Ter Lai -- $gCh. 84.$tUse of long-term (holter) electrocardiographic recordings /$rHarold L. Kennedy -- $gCh. 85.$tThe use of implantable loop recorders /$rAndrew D. Krahn, George J. Klein, Allan C. Skanes and Raymond Yee -- $gCh. 86.$tHigh-resolution electrocardiography /$rEdward J. Berbari -- $gCh. 87.$tBody surface potential mapping /$rBruno Taccardi and Bonnie B. Punske -- $gCh. 88.$tHead-up tilt table testing /$rDavid G. Benditt, Cengiz Ermis and Fei Lu -- $gCh. 89.$tHeart rate variability and baroreflex sensitivity /$rMark Malik -- $gCh. 90.$tMonophasic action potential recording /$rMichael R. Franz -- $gCh. 91.$tT-wave alternans /$rStefan H. Hohnloser -- $gCh. 92.$tNeurocardiac imaging /$rGary D. Hutchins, Michael A. Miller and Douglas P. Zipes -- $gCh. 93.$tMapping /$rVias Markides, Oliver R. Segal, Fernando Tondato and Nicholas S. Peters -- $gCh. 94.$tWolff-Parkinson-White syndrome /$rEric N. Prystowski, Raymond Yee and George J. Klein -- $gCh. 95.$tSinus node dysfunction /$rMichael O. Sweeney -- $gCh. 96.$tSyncope /$rHugh Calkins -- $gCh. 97.$tResults of clinical trials on atrial fibrillation /$rD. George Wyse -- $gCh. 98.$tResults of clinical trails of automatic external defibrillators and implantable cardioverter-defibrillators in patients at risk for sudden death /$rAlfred E. Buxton -- $gCh. 99.$tClass I antiarrhythmic drugs : quinidine, procainamide, disopyramide, lidocaine, mexiletine, flecainide and propafenone /$rAnne M. Gillis -- $gCh. 100.$t[beta]-blockers and calcium channel blockers as antiarrhythmic drugs /$rBramah N. Singh -- $gCh. 101.$tClass III antiarrhythmic drugs : amiodarone, ibutilide, and sotalol /$rTimothy W. Smith and Michael E. Cain -- $gCh. 102.$tAdenosine and digoxin /$rJohn P. DiMarco -- $gCh. 103.$tImpact of nontraditional antiarrhythmic drugs on sudden cardiac death /$rJeffrey Goldberger, Kenneth M. Weinberg and Alan H. Kadish -- $gCh. 104.$tNew antiarrhythmic drugs /$rN. A. Mark Estes III -- $gCh. 105.$tTransthoracic cardioversion and defibrillation /$rRichard E. Kerber -- $gCh. 106.$tImplantable cardioverter-defibrillator : technical aspects /$rBruce L. Wilkoff -- $gCh. 107.$tImplantable cardioverter-defibrillators : clinical aspects /$rCharles D. Swerdlow and Kalyanam Shivkumar -- $gCh. 108.$tImplantable atrial defibrillators for atrial fibrillation /$rSamuel Levy -- $gCh. 109.$tImplantable pacemakers /$rDavid L. Hayes -- $gCh. 110.$tNewer applications of pacemakers /$rMichael R. Gold and Robert W. Peters -- $gCh. 111.$tThe biophysics and pathophysiology of lesion formation during radiofrequency catheter ablation /$rDavid E. Haines -- $gCh. 112.$tCatheter ablation of atrial fibrillation : triggers and substrate /$rMichel Haissaguerre, Prashanthan Sanders, Pierre Jais, Meleze Hocini, Dipen C. Shah and Jacques Clementy -- $gCh. 113.$tPulmonary vein isolation for atrial fibrillation /$rCarlo Pappone and Salvatore Rosanio -- $gCh. 114.$tCatheter ablation of atrial flutter /$rHans Kottkamp and Gerhard Hindricks -- $gCh. 115.$tCatheter ablation of atrial tachycardia /$rChing-Feng Tsai, Ching-Tai Tai and Shih-Ann Chen -- $gCh. 116.$tCatheter ablation of atrioventricular nodal reentrant tachycardia /$rJonathan M. Kalman -- $gCh. 117.$tCatheter ablation of atrioventricular reentry /$rSabine Ernst, Feifan Ouyang, Matthias Antz, Riccardo Cappato and Karl-Heinz Kuck -- $gCh. 118.$tCatheter ablation of ventricular tachycardia /$rWilliam G. Stevenson and Kyoko Soejima -- $gCh. 119.$tCatheter ablation in pediatric patients /$rJohn D. Kugler -- $gCh. 120.$tSurgery for cardiac arrhythmias /$rPierre L. Page.
650 0 $aArrhythmia.$0http://id.loc.gov/authorities/subjects/sh85007430
650 0 $aHeart conduction system.$0http://id.loc.gov/authorities/subjects/sh85059743
650 0 $aElectrophysiology.$0http://id.loc.gov/authorities/subjects/sh85042443
650 12 $aArrhythmias, Cardiac.$0https://id.nlm.nih.gov/mesh/D001145
650 12 $aHeart$xphysiology.$0https://id.nlm.nih.gov/mesh/D006321Q000502
650 22 $aElectrophysiology.$0https://id.nlm.nih.gov/mesh/D004594
700 1 $aZipes, Douglas P.$0http://id.loc.gov/authorities/names/n80082996
700 1 $aJalife, José.$0http://id.loc.gov/authorities/names/n85098646
852 00 $boff,hsl$hRC685.A65$iZ56 2004 Q